CH622519A5 - Process for the preparation of hydroxyalkylxanthines - Google Patents

Process for the preparation of hydroxyalkylxanthines Download PDF

Info

Publication number
CH622519A5
CH622519A5 CH859275A CH859275A CH622519A5 CH 622519 A5 CH622519 A5 CH 622519A5 CH 859275 A CH859275 A CH 859275A CH 859275 A CH859275 A CH 859275A CH 622519 A5 CH622519 A5 CH 622519A5
Authority
CH
Switzerland
Prior art keywords
water
xanthine
acid
compounds
preparation
Prior art date
Application number
CH859275A
Other languages
German (de)
English (en)
Inventor
Alfons Dr Dipl Chem Soeder
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/485,869 external-priority patent/US4108995A/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CH622519A5 publication Critical patent/CH622519A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH859275A 1974-07-05 1975-07-02 Process for the preparation of hydroxyalkylxanthines CH622519A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48587074A 1974-07-05 1974-07-05
US05/485,869 US4108995A (en) 1973-07-11 1974-07-05 Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines

Publications (1)

Publication Number Publication Date
CH622519A5 true CH622519A5 (en) 1981-04-15

Family

ID=27048497

Family Applications (2)

Application Number Title Priority Date Filing Date
CH859275A CH622519A5 (en) 1974-07-05 1975-07-02 Process for the preparation of hydroxyalkylxanthines
CH331680A CH622018A5 (en) 1974-07-05 1980-04-29 Process for the preparation of novel monoalkenyldialkylxanthines

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH331680A CH622018A5 (en) 1974-07-05 1980-04-29 Process for the preparation of novel monoalkenyldialkylxanthines

Country Status (14)

Country Link
JP (1) JPS5250800B2 (lv)
AR (1) AR210330A1 (lv)
AT (1) AT339917B (lv)
CA (1) CA1062710A (lv)
CH (2) CH622519A5 (lv)
DK (1) DK140214B (lv)
ES (1) ES439141A1 (lv)
FI (1) FI59249C (lv)
FR (1) FR2277089A1 (lv)
GB (1) GB1500039A (lv)
LU (1) LU72897A1 (lv)
NL (1) NL166476C (lv)
NO (1) NO143224C (lv)
SE (2) SE420097B (lv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077298A (en) * 1984-01-12 1991-12-31 Sandoz Ltd. Novel 8α-acylaminoergolines

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077298A (en) * 1984-01-12 1991-12-31 Sandoz Ltd. Novel 8α-acylaminoergolines

Also Published As

Publication number Publication date
CH622018A5 (en) 1981-03-13
LU72897A1 (lv) 1976-05-31
NL166476B (nl) 1981-03-16
JPS5134194A (lv) 1976-03-23
JPS5250800B2 (lv) 1977-12-27
FR2277089A1 (fr) 1976-01-30
SE420097B (sv) 1981-09-14
ATA517275A (de) 1977-03-15
FI59249B (fi) 1981-03-31
SE7807853L (sv) 1978-07-14
AT339917B (de) 1977-11-10
DK301775A (lv) 1976-01-06
FR2277089B1 (lv) 1978-03-17
FI751958A (lv) 1976-01-06
ES439141A1 (es) 1977-02-16
SE427183B (sv) 1983-03-14
NO752423L (lv) 1976-01-06
AU8275575A (en) 1977-01-06
DK140214B (da) 1979-07-09
NO143224B (no) 1980-09-22
NO143224C (no) 1981-01-02
CA1062710A (en) 1979-09-18
FI59249C (fi) 1981-07-10
NL166476C (nl) 1981-08-17
DK140214C (lv) 1979-12-03
AR210330A1 (es) 1977-07-29
SE7507726L (sv) 1976-01-07
GB1500039A (en) 1978-02-08
NL7507976A (nl) 1976-01-07

Similar Documents

Publication Publication Date Title
DE2330742C2 (de) 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1443406A1 (de) Hydroxyalkyldextranverbindungen und Verfahren zu deren Herstellung
DE1620694C3 (de) Verfahren zur Herstellung von 5-Methyl-7-diäthylamino-s-triazolo [1,5-a] pyrimidin und seinen Salzen mit Säuren
DE1620048A1 (de) 6-Aza-uracile und Verfahren zu ihrer Herstellung
DE2160104A1 (de) Nucleosidderivate der purinreihe
DE2918261A1 (de) Neue purinderivate, verfahren zu deren herstellung, sie enthaltende arzneimittel und zwischenprodukte
DE2432702C2 (de) Verfahren zur Herstellung von Hydroxyalkylxanthinen
CH622519A5 (en) Process for the preparation of hydroxyalkylxanthines
DE60312543T2 (de) Herstellung von codein aus morphin
DE1545645A1 (de) Verfahren zur Herstellung von disubstituierten Adenosin-Derivaten
DE812316C (de) Verfahren zur Herstellung von 2-(p-Aminobenzolsulfonamido)-4-methylpyrimidin
AT339918B (de) Verfahren zur herstellung von mono- (hydroxyalkyl) -di-alkylxanthinen
AT343678B (de) Verfahren zur herstellung von neuen monoalkenyldialkylxanthinen
DE2652165A1 (de) Verfahren zur herstellung von vincamin und epi-vincamin aus (-)tabersonin
DE2832857A1 (de) Verfahren zur herstellung wasserloeslicher hydroxy-flavonaether
DE2026040A1 (de) Imidazolnbosylcyclophosphate
AT224274B (de) Verfahren zur Herstellung von tert. Alkylaminsalzen von Steroidphosphatestern
DE1011888B (de) Verfahren zur Herstellung von Theophyllinderivaten
DE2218215C3 (de) 2',3'-O-Sulfinylcytidin und ein Verfahren zur Herstellung von 22'-Anhydro-(i-beta-D-arabinofuranosyl) -cytosin
DE696810C (de) Verfahren zur Herstellung von Ascorbinsaeure
AT209007B (de) Verfahren zur Herstellung von 9 α-Halogen-4-pregnen-16 α, 17 α,21-triol-3, 11, 20-trionen und ihren Estern
DE695317C (de) Verfahren zur Gewinnung des Adenosins aus dem entsprechenden Pikrat
AT227265B (de) Verfahren zur Herstellung des neuen Kampfersulfonats des 2-Amino-4-methylpyridins
AT132842B (de) Verfahren zur Gewinnung herzwirksamer Substanzen in gereinigter Form.
DE1950075C2 (de) Verfahren zur Herstellung von 4-Chlorpyrazolo- eckige Klammer auf 3,4-d eckige Klammer zu pyrimidin

Legal Events

Date Code Title Description
PL Patent ceased